Atalauren

Lastar1

New member
Thank you. Just saw this as well. I have only been waiting for 10 YEARS! Hope this is good enough for FDA approval.
Lisa, mom to 3, one 11 year old w/cf
 
E

echolaura

Guest
Does anybody know what the data given so far, translates to percentages? All I have heard is that there is "decrease in decline of function" and decreased exacerbations, but I get the feeling that the results haven't been as dramatic as the avg 10% seen with Kalydeco (ivacaftor) Congrats to all you nonsense mutations!
 
Top